[HTML] mdpi.com

[HTML][HTML] Greek Remdesivir Cohort (GREC) study: effectiveness of antiviral drug remdesivir in hospitalized patients with COVID-19 pneumonia

V Petrakis, V Rapti, K Akinosoglou, C Bonelis… - Microorganisms, 2022 - mdpi.com
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery
period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as …
被引用次数：5 相关文章

Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia.

V Petrakis, V Rapti, K Akinosoglou, C Bonelis… - …, 2022 - search.ebscohost.com
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery
period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as …

Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia

V Petrakis, V Rapti, K Akinosoglou, C Bonelis… - …, 2022 - search.proquest.com
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery
period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as …

Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia

V Petrakis, V Rapti, K Akinosoglou… - …, 2022 - pubmed.ncbi.nlm.nih.gov
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery
period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as …

Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia.

V Petrakis, V Rapti, K Akinosoglou, C Bonelis… - …, 2022 - europepmc.org
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery
period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as …
[HTML] nih.gov

[HTML][HTML] Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia

V Petrakis, V Rapti, K Akinosoglou, C Bonelis… - …, 2022 - ncbi.nlm.nih.gov
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery
period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as …

Greek remdesivir cohort (GREC) study: effectiveness of antiviral drug remdesivir in hospitalized patients with COVID-19 pneumonia.

V Petrakis, V Rapti, K Akinosoglou, C Bonelis… - 2022 - cabidigitallibrary.org
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery
period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as …

Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia.

V Petrakis, V Rapti, K Akinosoglou, C Bonelis… - …, 2022 - go.gale.com
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery
period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as …

Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia

V Petrakis, V Rapti, K Akinosoglou, C Bonelis… - agris.fao.org
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery
period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as …
[PDF] semanticscholar.org

[PDF][PDF] Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia. Microorganisms 2022 …

V Petrakis, V Rapti, K Akinosoglou, C Bonelis… - 2022 - pdfs.semanticscholar.org
In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery
period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as …